Keywords: novo, nordisk, first-half, sales, rise, copenhagen, denmark-headquartered
Novo Nordisk's first-half sales rise 15%
Article | 22 August 2005
Copenhagen, Denmark-headquartered drugmaker Novo Nordisk says that its revenue in the first half of 2005 increased 15% on the like, year-ago period. ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Elan makes "transformational" acquisitions and a divestment
